These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 34018203)

  • 1. Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin.
    Niu S; Wang J; Bai B; Wu L; Zheng A; Chen Q; Du P; Han P; Zhang Y; Jia Y; Qiao C; Qi J; Tian WX; Wang HW; Wang Q; Gao GF
    EMBO J; 2021 Aug; 40(16):e107786. PubMed ID: 34018203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
    Niu S; Zhao Z; Liu Z; Rong X; Chai Y; Bai B; Han P; Shang G; Ren J; Wang Y; Zhao X; Liu K; Tian W-x; Wang Q; Gao GF
    J Virol; 2024 Mar; 98(3):e0115723. PubMed ID: 38305152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2.
    Wrobel AG; Benton DJ; Xu P; Calder LJ; Borg A; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nat Commun; 2021 Feb; 12(1):837. PubMed ID: 33547281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
    Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.
    Zhang S; Qiao S; Yu J; Zeng J; Shan S; Tian L; Lan J; Zhang L; Wang X
    Nat Commun; 2021 Mar; 12(1):1607. PubMed ID: 33707453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host.
    Lopes LR; de Mattos Cardillo G; Paiva PB
    Braz J Microbiol; 2020 Dec; 51(4):1593-1599. PubMed ID: 32592038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
    Liu MQ; Lin HF; Li J; Chen Y; Luo Y; Zhang W; Hu B; Tian FJ; Hu YJ; Liu YJ; Jiang RD; Gong QC; Li A; Guo ZS; Li B; Yang XL; Tong YG; Shi ZL
    J Virol; 2023 Feb; 97(2):e0171922. PubMed ID: 36688655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    Jin H; Cheng L; Gong Y; Zhu Y; Chong H; Zhang Z; He Y
    J Virol; 2023 Aug; 97(8):e0019223. PubMed ID: 37578234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017.
    Jia Y; Niu S; Hu Y; Chai Y; Zheng A; Su C; Wu L; Han P; Han P; Lu D; Liu Z; Yan X; Tian D; Chen Z; Qi J; Tian WX; Wang Q; Gao GF
    Cell Rep; 2022 Dec; 41(11):111831. PubMed ID: 36493785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein.
    Ma S; Li H; Yang J; Yu K
    Biochimie; 2021 Aug; 187():1-13. PubMed ID: 33984400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
    Mou H; Quinlan BD; Peng H; Liu G; Guo Y; Peng S; Zhang L; Davis-Gardner ME; Gardner MR; Crynen G; DeVaux LB; Voo ZX; Bailey CC; Alpert MD; Rader C; Gack MU; Choe H; Farzan M
    PLoS Pathog; 2021 Apr; 17(4):e1009501. PubMed ID: 33836016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a pangolin SARS-CoV-2-related virus isolate that uses the human ACE2 receptor.
    Xia LY; Wang XF; Cui XM; Zhang YM; Wang ZF; Li ET; Fan CF; Song K; Li YG; Ye RZ; Li FX; Zhu DY; Zhang J; Shi ZZ; Zhang MZ; Li LJ; Shen SJ; Jin S; Zhang YW; Fu WG; Zhao L; Wang WH; Wang TC; Wang YC; Jiang JF; Hu YL; Jia N; Gao YW; Cao WC
    Sci China Life Sci; 2024 Jul; 67(7):1502-1513. PubMed ID: 38478297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses.
    Xu Z; Kang X; Han P; Du P; Li L; Zheng A; Deng C; Qi J; Zhao X; Wang Q; Liu K; Gao GF
    Nat Commun; 2022 Jun; 13(1):3547. PubMed ID: 35729237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.
    Malaiyan J; Arumugam S; Mohan K; Gomathi Radhakrishnan G
    J Med Virol; 2021 Jan; 93(1):499-505. PubMed ID: 32633815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
    Yang R; Han P; Han P; Li D; Zhao R; Niu S; Liu K; Li S; Tian W-X; Gao GF
    J Virol; 2024 May; 98(5):e0045124. PubMed ID: 38591877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
    Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
    J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
    Wan Y; Shang J; Graham R; Baric RS; Li F
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31996437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.